January 1996

Interleukin-10 Attenuates the Release of Proinflammatory Cytokines but Depresses Splenocyte Functions in Murine Endotoxemia

Author Affiliations

From the Division of Trauma Surgery, Department of Surgery, University of Zurich (Switzerland).

Arch Surg. 1996;131(1):51-56. doi:10.1001/archsurg.1996.01430130053009

Objective:  To determine whether interleukin (IL)-10, besides its potent anti-inflammatory properties, causes depression of splenocyte functions in a murine model of gram-negative endotoxemia.

Design:  Mice (strain C3H/HeN) were injected intravenously with 1 mg of Escherichia coli lipopolysaccharide at 15 minutes after intravenous injection of either 200 U of recombinant murine IL-10 or saline solution. Serum levels of tumor necrosis factor α, IL-6, and IL-1α were determined at 90 minutes and 12 hours after lipopolysaccharide challenge. In addition, splenocyte proliferation and lymphokine release (IL-2, IL-6, and interferon gamma) were measured.

Results:  Pretreatment with IL-10 markedly reduced (P<.05) serum levels of tumor necrosis factor α (−79%), IL-6 (−94%), and IL-1α (−69%), but it significantly inhibited splenocyte proliferation (−32%) and IL-2 (−40%), IL-6 (−49%), and interferon gamma (−54%) release of splenocytes.

Conclusions:  Interleukin-10 prevents E coli lipopolysaccharide—induced cytokinemia but dampens antigen-driven cellular immune responses. Although IL-10 protects against the detrimental effects of proinflammatory cytokines by deactivation of macrophages, its immunosuppressive effect may augment susceptibility to repeated or continuous invasion of microorganisms, as it is observed during clinical sepsis.(Arch Surg. 1996;131:51-56)